研究结果:HIV PrEP队列(n=327)和HIV感染者队列(n=174)细菌性STI的相对风险(RR)均有所降低,包括淋病(RR 0.45,95%CI:0.34～0.65;RR 0.45,95%CI:0.34～0.65)、衣原体(RR 0.12,95%CI:0.05～0.25;RR 0.26,95%CI:0.12～0.57)和梅毒(RR 0.13,95%CI:0.03～0.59;RR 0.23,95%CI:0.04～1.29)。 法国ANRS D...
研究结果:HIV PrEP队列(n=327)和HIV感染者队列(n=174)细菌性STI的相对风险(RR)均有所降低,包括淋病(RR 0.45,95%CI:0.34～0.65;RR 0.45,95%CI:0.34～0.65)、衣原体(RR 0.12,95%CI:0.05～0.25;RR 0.26,95%CI:0.12～0.57)和梅毒(RR 0.13,95%CI:0.03～0.59;RR 0.23,95%CI:0.04～1.29)。 法国ANRS D...
"PrEP is a new approach to HIV prevention that requires continuing collaboration between patients and providers, as effectiveness requires adherence to daily medication and regular medical visits for monitoring, counseling and testing," Smith said. The new guidelines were published May 14 in the CDC ...
CDC says all sexually active patients should be told about HIV PrEPThe CDC on Wednesday recommended that all sexually active adult and adolescent patients be informed about HIV PrEP.Caitlyn StulpinInfectious Disease News
For patients with HIV who have used long acting cabotegravir as PrEP, INSTI resistance testing should be done before starting ART. If ART is started before the genotype test results are known, then the following regimen is recommended: Boosted darunivir plus either tenofovir alafenamide or tenofo...
STI rates are significant with approximately 1/5 of patients testing positive, although active HBV and HCV infections were very low for those utilizing PrEP. DISCLOSURES. Charles M. Walworth, MD, Labcorp: Employee|Labcorp: Employee|Labcorp: Stocks/Bonds (Public Company) Laura Gillim, PhD, Lab...
of work to do in healthcare settings in order to get all of our healthcare personnel vaccinated," Srinivasan toldMedscape Medical News. "We need them to be vaccinated to protect themselves. It is also really important that we as healthcare personnel get vaccinated to protect our patients."...
PCPs Prep for 'Less Predictable' Respiratory Virus Season World Falls Short on HBV, HCV Elimination Targets Recommended Reading Diseases & Conditions Hepatitis D Hepatitis B Vaccination Rates Lag in Patients With Psoriasis Diseases & Conditions Hepatitis B Diseases & Conditions Treatment Recommendat...
Sign up for Morning Rounds Understand how science, health policy, and medicine shape the world every day Privacy Policy Use of PrEP Among the respondents, more than 900 were HIV-negative and were therefore eligible to use PrEP. It’s often taken as a daily pill that can be99%effective in...
Liver cancer is one of the most commonly diagnosed cancers and the fourth leading cause of cancer-related death worldwide. Broad-spectrum kinase inhibitors like sorafenib and lenvatinib provide only modest survival benefit to patients with hepatocellular